Cognition Therapeutics (CGTX) just unveiled an update.
Cognition Therapeutics, Inc. has prepared a presentation for investors, analysts, and other interested parties that it may use intermittently. This presentation is part of a regulatory compliance effort under Regulation FD, but it is not considered part of the company’s formal legal filings with the SEC and is not intended to carry any legal liability as such.
See more data about CGTX stock on TipRanks’ Stock Analysis page.
